Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-475
Closed -$231K 223
2023
Q3
$231K Hold
475
0.02% 188
2023
Q2
$212K Hold
475
0.01% 201
2023
Q1
$231K Hold
475
0.02% 135
2022
Q4
$243K Sell
475
-104
-18% -$54.7K 0.02% 146
2022
Q3
$281K Buy
579
+4
+0.7% +$1.95K 0.02% 133
2022
Q2
$269K Sell
575
-85
-13% -$37.8K 0.02% 143
2022
Q1
$287K Hold
660
0.02% 120
2021
Q4
$306K Hold
660
0.02% 129
2021
Q3
$257K Hold
660
0.02% 134
2021
Q2
$292K Hold
660
0.02% 123
2021
Q1
$277K Sell
660
-3
-0.5% -$1.2K 0.02% 125
2020
Q4
$272K Buy
663
+3
+0.5% +$1.25K 0.02% 123
2020
Q3
$273K Hold
660
0.02% 112
2020
Q2
$256K Hold
660
0.02% 115
2020
Q1
$207K Sell
660
-77
-10% -$26K 0.02% 123
2019
Q4
$270K Buy
+737
New +$234K 0.02% 133

Other funds holding HUM

Sabal Trust's HUM Position: Q4 2023 in Review

Sabal Trust sold out of Humana (HUM) in Q4 2023, closing a stake of 475 shares — an estimated $231K sold.

Sabal Trust first reported a position in HUM in Q4 2019 and held it in 16 quarters. The position peaked at $306K in Q4 2021. 1,153 funds tracked by Wall St. Rank hold HUM as of Q4 2023.

  • Sabal Trust reported no remaining Humana position as of Q4 2023 after selling out during the quarter.
  • Sabal Trust sold 475 Humana shares in Q4 2023, an estimated $231K.
  • Sabal Trust first reported a position in Humana in Q4 2019 and held it in 16 quarters.
  • Sabal Trust's Humana position peaked at $306K in Q4 2021.
  • 1,153 funds tracked by Wall St. Rank held Humana as of Q4 2023.

Based on Sabal Trust's 13F filing for Q4 2023, filed 25 Jan 2024.